De novo tacrolimus-based immunosuppression reduces renal allograft fibrosis compared to neoral:: a prospective randomized clinical trial

被引：0
|
作者：
Murphy, GJ [1 ]
Waller, JR [1 ]
Sandford, R [1 ]
Nicholson, ML [1 ]
机构：
[1] Univ Leicester, Leicester Gen Hosp, Dept Surg, Leicester LE5 4PW, Leics, England
来源：
BRITISH JOURNAL OF SURGERY | 2002年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [31] LONG-TERM PROLONGED-RELEASE TACROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO KIDNEY TRANSPLANT PATIENTS: 3-YEAR PROSPECTIVE FOLLOW-UP OF THE ADHERE STUDY
    Kuypers, Dirk
    Kazeem, Gbenga
    Hurst, Martin
    TRANSPLANT INTERNATIONAL, 2017, 30 : 291 - 291
  • [32] LONG-TERM PROLONGED-RELEASE TACROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO KIDNEY TRANSPLANT PATIENTS: 3-YEAR PROSPECTIVE FOLLOW-UP OF THE ADVANCE STUDY
    Mourad, Georges
    Kazeem, Gbenga
    Hurst, Martin
    TRANSPLANT INTERNATIONAL, 2017, 30 : 290 - 291
  • [33] LONG-TERM PROLONGED-RELEASE TACROLIMUS-BASED IMMUNOSUPPRESSION IN DE NOVO LIVER TRANSPLANT PATIENTS: 3-YEAR PROSPECTIVE FOLLOW-UP OF THE DIAMOND STUDY
    Trunecka, Pavel
    Kazeem, Gbenga
    Hurst, Martin
    TRANSPLANT INTERNATIONAL, 2017, 30 : 79 - 80
  • [34] Pediatric cardiac transplantation: A randomized clinical trial of tacrolimus versus cyclosporine-based immunosuppression
    Pollock-BarZiv, SM
    Dipchand, AI
    McCrindle, BW
    West, LJ
    CIRCULATION, 2003, 108 (17) : 466 - 466
  • [35] Tubular epithelial cell and podocyte apoptosis with de novo sirolimus based immunosuppression in renal allograft recipients with DGF
    Munivenkatappa, R.
    Haririan, A.
    Papadimitriou, J. C.
    Drachenberg, C. B.
    Dinits-Pensy, M.
    Klassen, D. K.
    HISTOLOGY AND HISTOPATHOLOGY, 2010, 25 (02) : 189 - 196
  • [36] Induction With and Without Antithymocyte Globulin Combined With Cyclosporine/Tacrolimus-Based Immunosuppression in Renal Transplantation: A Meta-analysis of Randomized Controlled Trials
    Tian, J. H.
    Wang, X.
    Yang, K. H.
    Liu, A. P.
    Luo, X. F.
    Zhang, J.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (09) : 3671 - 3676
  • [37] Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Koneru, B.
    Huang, M. A.
    Chapman, W. C.
    Foltys, D.
    Witte, S.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (11) : 3008 - 3020
  • [38] Five Years Results of De Novo Kidney Transplant Recipients Treated with the Combination of Low Dose Tacrolimus and Everolimus: A Prospective Randomized Clinical Trial
    Silvestri, P.
    Spagnoletti, G.
    Salerno, M.
    Favi, E.
    Zanoni, N.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S449 - S449
  • [39] A PROSPECTIVE CLINICAL TRIAL COMPARING TACROLIMUS-MMF TO CYCLOSPORINE-EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS: 2 YEARS RESULTS
    Favi, Evaldo
    Citterio, Franco
    Spagnoletti, Gionata
    Gargiulo, Antonio
    Romagnoli, Jacopo
    Castagneto, Marco
    TRANSPLANT INTERNATIONAL, 2009, 22 : 241 - 241
  • [40] Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients
    de Boer, S. E.
    Sanders, J. S. F.
    Bemelman, F. J.
    Betjes, M. G. H.
    Burgerhof, J. G. M.
    Hilbrands, L.
    Kuypers, D.
    van Munster, B. C.
    Nurmohamed, S. A.
    de Vries, A. P. J.
    van Zuilen, A. D.
    Hesselink, D. A.
    Berger, S. P.
    BMC NEPHROLOGY, 2021, 22 (01)
12345